Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Melanion Capital launches first hedge fund focused on dividend futures

Monday, July 08, 2013
Opalesque Industry Update - Melanion Capital, Paris has received authorization from the French Autorité des Marchés Financiers to become the first alternative manager to specialize in investment in dividend futures.

Led by Jad Comair, founder and CIO, the Melanion team traces its track record and expertise in dividend futures (at a leading French investment bank) from 2008, the year of the first listing of a dividend future on Eurex. Since 2008, the dividend futures market has expanded in volume, in the number of traded instruments (single stocks, indices, options, etc), the number of exchanges issuing these contracts (Eurex, NYSE Euronext, MEFF, LSE, Tokyo, Singapore etc.) and the number of market participants (institutions, banks, family offices and others).

Other members of the Melanion team include : Portfolio Manager : Antoine Iskandar, Risk Manager: Dr Bing Zhou, and Business Development Manager : Erwan Tigreat.

Since inception in 2008, the trading strategy employed by Melanion Capital has generated an average gross return of 20%+ per annum, compared to a 2% average decline in the EuroStoxx50 during the same period as the impact of the global financial crisis took hold.

“This strong demonstration of alpha generation is a key validation of the Melanion Capital investment approach,” said Founder and Chief Investment Officer, Jad Comair who went on to explain that his firm will employ: “Quant and fundamental elements including bottom-up analysis, stock-picking, yield strategies and arbitrage to achieve its performance objectives.

“Because they’re simple, easy to understand and answers investors’ need to hedge their dividend exposure, dividend futures have become very popular since 2008 in an environment where other assets were losing momentum after the financial crisis. Melanion Capital’s unique business model aims at capturing the opportunities in these derivatives while seeing them become the asset class of the next decade,” Jad Comair added. “Our investment team was there at the beginning and established itself through the difficult days of 2008 and 2010. We firmly believe that Melanion Capital embodies a ‘first mover advantage’ in this sector and we look forward to being able to demonstrate our strengths and our ability to create alpha, on behalf of investors, in a wide range of market conditions.”

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und